Health In Tech (HIT) EBITDA Margin (2024 - 2026)

Health In Tech has reported EBITDA Margin for 3 years, with the latest figure at 42.43% in Q2 2026.

• On a quarterly basis, EBITDA Margin fell 5000.0% year-over-year to 42.43% in Q2 2026; TTM through Jun 2026 was 6.51%, a 1125.0% decrease from a year earlier, with the FY2025 full-year figure at 4.07%, down 98.0% from the prior year.
• EBITDA Margin was 42.43% for Q2 2026 at Health In Tech, down from 1.87% in the prior quarter.
• The five-year high for EBITDA Margin was 10.69% in Q2 2024, with the low at 42.43% in Q2 2026.
• Average EBITDA Margin over 3 years is 0.64%, with a median of 5.38% recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: EBITDA Margin soared 445 bps in 2025, then tumbled 5000 bps in 2026.
• Over 3 years, EBITDA Margin stood at 6.32% in 2024, then soared by 70 bps to 1.87% in 2025, then slumped by 2166 bps to 42.43% in 2026.
• The last three EBITDA Margin figures came in at 42.43% (Q2 2026), 1.87% (Q4 2025), and 4.97% (Q3 2025), per Business Quant data.